Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol as Secondary Treatment in Gout
NCT03601260Unknown
- Sponsor
- Hillel Yaffe Medical Center
- Start
- Aug 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of allopurinol in gout, sponsored by Hillel Yaffe Medical Center. Primary endpoint: Percentage of Gout Patients Treated with Allopurinol at 6 months. Status: unknown.
02
Drugs
allopurinol
03
Conditions
gout
Beyond the preview
Go deeper on NCT03601260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03601260.